News and Events
closerlook announces promotion of Amy Wolgemuth Bordoni as vice president, executive creative director
Chicago, Ill., October 25, 2020 — Biopharma digital-marketing agency closerlook, inc., has announced the promotion of Amy Wolgemuth Bordoni to vice president, executive creative director. The promotion advances Bordoni to the closerlook executive team, where she will help shape the agency’s business growth and culture.
“Amy has been crucial in driving creative excellence at closerlook and in growing our client relationships across a range of brands,” said Dave Reidy, chief creative officer. “Amy is also an exceptional leader. She has done so much to develop the talent, empathy and confidence of the next generation of creative leaders at closerlook.”
According to Reidy, Bordoni will continue to oversee the hiring of creative team members while directing award-winning work and delivering innovative solutions for closerlook clients.
“Amy is a true leader and mentor in every sense. I have learned so much while working on a team led by her,” said Nicole Ngo, senior art director. “Her ability to create, shape and push the work is unmatched, and we are all very fortunate to have her at the agency.”
Bordoni has been with closerlook since 2012, starting as a copywriter and working her way up through the ranks of creative leadership. She is an award-winning creative director who has received industry recognition on five campaigns, including a best-in-show award for patient education.
Bordoni graduated from Duke University with a bachelor’s degree in English.
Content marketing and its impact on pharma
Content marketing is one of the most practical ways that a brand can engage its audience and provide value on a regular basis.Read more
Courtney Kuebler talks about closerlook’s collaborative culture with Built In Chicago
“Starting a new job, and working on a new team with a new client during a global pandemic, was a little daunting…”Read more
Brand Stewards: Creating an omnichannel experience for HCPs and patients
CEO David Ormesher leads a PharmaVOICE 100 panel discussing the creation of content platforms to support patients and HCPsLearn more